KU 2019 Post San Antonio Breast Cancer Review

 

KU 2019 Post San Antonio Breast Cancer Review
Avatar

SABCS 2019 Highlights on Adjuvant Therapy Options for HER2+ Breast Cancer: Outcomes of KATHERINE, APHINITY & ATEMPT Trials, De-escalation Strategies Will Dominate

By KU 2019 Post San Antonio Breast Cancer Review FEATURING William Gradishar
By KU 2019 Post San Antonio Breast Cancer Review FEATURING William Gradishar
0 views
March 12, 2020
Comments 0
Login to view comments. Click here to Login

Featured Video

02:58
Lilly Medical Affairs

A Heterogenous Disease with Varied Clinical Outcomes: HR+/HER2- MBC

Feat. J. O’Shaughnessy

Featured Video

03:57
Lilly Medical Affairs

Resistance Mechanisms to ET, Including ESR1 Mutations in HR+, HER2- …

Feat. K. Jhaveri
Videos
17:37
KU 2019 Post San Antonio Breast Cancer Review

SABCS 2019 Highlights on Metastatic HER2+ Breast Cancer: Outcomes of…

Feat. W. Gradishar
11:53
KU 2019 Post San Antonio Breast Cancer Review

SABCS 2019 Highlights on Metastatic HER2+ Breast Cancer Management: …

Feat. W. Gradishar
10:29
KU 2019 Post San Antonio Breast Cancer Review

SABCS 2019 Highlights on Adjuvant Therapy Options for HER2+ Breast C…

Feat. W. Gradishar
18:55
KU 2019 Post San Antonio Breast Cancer Review

SABCS 2019 Highlights on Early Stage TNBC: 5-FU Has a Benefit, Neoad…

Feat. V. Kaklamani
06:40
KU 2019 Post San Antonio Breast Cancer Review

SABCS 2019 Highlights on IO in mTNB: IMpassion130 Suggest PD-L1+ Pts…

Feat. V. Kaklamani
09:08
KU 2019 Post San Antonio Breast Cancer Review

SABCS 2019 Updates on Breast Cancer Chemoprevention: Anastrozole Sig…

Feat. T. Mamounas
23:29
KU 2019 Post San Antonio Breast Cancer Review

SABCS 2019 Updates on Early Stage HR+: Oral Formulation S-1 + Adjuva…

Feat. T. Mamounas
07:01
KU 2019 Post San Antonio Breast Cancer Review

SABCS 2019 Updates on Metastatic HR+ BC: PEARL Suggests Treatment Wi…

Feat. T. Mamounas
11:46
KU 2019 Post San Antonio Breast Cancer Review

52 y/o With HER2+/HR- De-novo Metastatic BC / 52 y/o With T2N0 HR+/H…

Feat. A. Kurian, Q. Khan, P. Sharma, V. Kaklamani, T. Mamounas, W. Gradishar
11:23
KU 2019 Post San Antonio Breast Cancer Review

46 y/o F With Grade 2, 2.5 cm, NO ER+ Left BC / 40 y/o Premenopausal…

Feat. A. Kurian, Q. Khan, P. Sharma, V. Kaklamani, T. Mamounas, W. Gradishar
08:39
KU 2019 Post San Antonio Breast Cancer Review

55 y/o Diagnosed With T3NO TNBC / 42 y/o With cT2N+ Grade IlTNBC, Re…

Feat. A. Kurian, Q. Khan, P. Sharma, V. Kaklamani, T. Mamounas, W. Gradishar